Abdominelle Sonographie
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sienz M, Ignee A, Dietrich CF (2010) Reference values in abdominal ultrasound — liver and liver vessels. Z Gastroenterol 48: 1141–1152
Nürnberg D, Ignee A, Dietrich CF (2006) Ultrasound in gastroenterology — liver and spleen. Z Gastroenterol 44: 991–1000
Friedrich-Rust M, Nierhoff J, Lupsor M et al (2012) Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 19: e212–e219
EFSUMB (2012) European course book. London: European Federation of Societies for Ultrasound in Medicine and Biology
Dietrich CF, Nürnberg D (2011) Interventioneller Ultraschall. Lehrbuch und Atlas für die interventionellen Sonographie. Thieme, Stuttgart
EFSUMB (2012) Cases of the month. London: European Federation of Societies for Ultrasound in Medicine and Biology
Braden B, Faust D, Ignee A et al (2008) Clinical relevance of perihepatic lymphadenopathy in acute and chronic liver disease. J Clin Gastroenterol 42: 931–936
Dietrich CF, Lee JH, Herrmann G et al (1997) Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 26: 467–472
Hirche TO, Russler J, Braden B et al (2004) Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease. Int J Colorectal Dis 19: 586–594
Dietrich CF, Lee JH, Gottschalk R et al (1998) Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. Am J Roentgenol 171: 437–443
Hirche TO, Ignee A, Hirche H et al (2007) Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection. Liver Int 27: 748–757
Barreiros AP, Otto G, Ignee A et al (2009) Sonographic signs of amyloidosis. Z Gastroenterol 47: 731–739
Berzigotti A, Piscaglia F (2011) Ultrasound in portal hypertension — part 1. Ultraschall Med 32: 548–568
Dietrich CF, Schreiber-Dietrich D, Schuessler G, Ignee A (2007) Contrast enhanced ultrasound of the liver — state of the art. Dtsch Med Wochenschr 132: 1225–1231
Westwood M, Joore M, Grutters J et al (2013) Contrast-enhanced ultrasound using SonoVue(R) (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess 17: 1–243
Schuler A, Reuss J, Delorme S et al (2010) Costs of clinical ultrasound examinations — an economical cost calculation and analysis. Ultraschall Med 31: 379–386
Gottschalk U, Ignee A, Dietrich CF (2010) Ultrasound-guided interventions and description of the equipment. Z Gastroenterol 48: 1305–1316
Gottschalk U, Ignee A, Dietrich CF (2009) Ultrasound guided interventions, part 1: diagnostic procedures. Z Gastroenterol 47: 682–690
Dietrich CF, Ignee A, Trojan J et al (2004) Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 53: 401–405
Dietrich CF, Averkiou M, Correas J et al (2012) An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCEUS) for quantification of tumour perfusion. Ultraschall Med 33: 344–351
Dietrich CF, Kratzer W, Strobe D et al (2006) Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 12: 1699–1705
Strobel D, Seitz K, Blank W et al (2009) Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 30: 376–382
Strobel D, Seitz K, Blank W et al (2008) Contrast-enhanced ultrasound for the characterization of focal liver lesions — diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 29: 499–505
Seitz K, Greis C, Schuler A et al (2011) Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall Med 32: 598–603
Bernatik T, Seitz K, Blank W et al (2010) Unclear focal liver lesions in contrast-enhanced ultrasonography — lessons to be learned fromthe DEGUM multicenter study for the characterization of liver tumors. Ultraschall Med 31: 577–581
Claudon M, Cosgrove D, Albrecht T et al (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) — update 2008. Ultraschall Med 29: 28–44
Piscaglia F, Nolsoe C, Dietrich CF et al (2012) The EFSUMB guidelines and recommendations on the clinical practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33: 33–59
Claudon M, Dietrich CF, Choi BI et al (2013) Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver — Update 2012. Ultraschall Med 34: 11–29
Dietrich CF, Mertens JC, Braden B et al (2007) Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 45: 1139–1145
Dietrich CF, Schuessler G, Trojan J et al (2005) Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 78: 704–707
Dietrich CF, Maddalena ME, Cui XW et al (2012) Liver tumor characterization — review of the literature. Ultraschall Med 33 (Suppl 1): S3–S10
Dietrich CF (2012) Liver tumor characterization — comments and illustrations regarding guidelines. Ultraschall Med 33 (Suppl 1): S22–S30
Dietrich CF, Ignee A, Hocke M et al (2011) Pitfalls and artefacts using contrast enhanced ultrasound. Z Gastroenterol 49: 350–356
Ignee A, Piscaglia F, Ott M et al (2009) A benign tumour of the liver mimicking malignant liver disease — cholangiocellular adenoma. Scand J Gastroenterol 44: 633–636
Ignee A, Baum U, Schuessler G, Dietrich CF (2009) Contrast-enhanced ultrasound-guided percutaneous cholangiography and cholangiodrainage (CEUS-PTCD). Endoscopy 41: 725–726
Heinzmann A, Muller T, Leitlein J et al (2012) Endocavitary contrast enhanced ultrasound (CEUS) — work in progress. Ultraschall Med 33: 76–84
Dietrich CF (2010) Letter to the editor: Kratzer W et al. Prevalence and risk factors of focal sparing in hepatic steatosis. Ultraschall Med 31: 37–42, 417–419
Dietrich CF (2008) Comments and illustrations regarding the guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) — update 2008. Ultraschall Med 29 (Suppl 4): S188–S202
Ignee A, Weiper D, Schuessler G et al (2005) Sonographic characterisation of hepatocellular carcinoma at time of diagnosis. Z Gastroenterol 43: 289–294
Dietrich CF (2012) Liver tumor characterization — comments and illustrations regarding guidelines. Ultraschall (Suppl) (epub in advance)
Barreiros AP, Piscaglia F, Dietrich CF (2012) Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol 57: 930–932
Dietrich CF, Cui XW, Boozari B et al (2012) Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithmof hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines. Ultraschall Med 33 (Suppl 1): S57–S66
Trojan J, Hammerstingl R, Engels K et al (2010) Contrast-enhanced ultrasound in the diagnosis of malignant mesenchym esenchym esenchy al liver tumors. J Clin Ultrasound 38: 227–231
Mork H, Ignee A, Schuessler G et al (2007) Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Scand J Gastroenterol 42: 652–662
Schacherer D, Wrede C, Obermeier F et al (2006) Comparison of low and high frequency transducers in the detection of liver metastases. Dig Liver Dis 38: 677–682
Stang A, Keles H, Hentschke S et al (2011) Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma frommalignant lesions? Ultraschall Med 32: 582–592
Sienz M, Ignee A, Dietrich CF (2011) Reference values in abdominal ultrasound — biliopancreatic systemand spleen. Z Gastroenterol 49: 845–870
Dietrich CF, Zeuzem S, Caspary WF, Wehrmann T (1998) Ultrasound lymph node imaging in the abdomen and retroperitoneumof healthy probands. Ultraschall Med 19: 265–269
Gorg C, Faoro C, Bert T et al (2011) Contrast enhanced ultrasound of splenic lymphoma involvement. Eur J Radiol 80: 169–174
Bert T, Tebbe J, Gorg C (2010) What should be done with echoic splenic tumors incidentally found by ultrasound? Z Gastroenterol 48: 465–471
Gorg C, Gorg K, Bert T, Barth P (2006) Colour Doppler ultrasound patterns and clinical follow-up of incidentally found hypoechoic, vascular tumours of the spleen: evidence for a benign tumour. Br J Radiol 79: 319–325
Herbay A von, Barreiros AP, Ignee A et al (2009) Contrast-enhanced ultrasonography with SonoVue: differentiation between benign and malignant lesions of the spleen. J Ultrasound Med 28: 421–434
Dietrich CF, Cui XW, Barreiros AP et al (2012) EFSUMB Guidelines 2011: Comment on emergent indications and visions. Ultraschall Med 33 (Suppl 1): 39–47